At present, data on drugs targeting ABCG2 transcription, internalization, and stability are quite scarce or preliminary but clearly warranted, along with extensive studies on cellular pathways specifically activated in leukemia cells and efforts toward the standardization of methods to evaluate protein expression and function. Here, ABCG2 is linked to leukemia.